Cell Culture Technology– category –
-
Chemically Defined, Serum-Free Media Innovations Drive Market Expansion: AuctuCel Launches AI-Powered Medium, Gibco Achieves High CHO Cell Titer
Media City Scientific Singapore Overview Innovations in serum-free and chemically defined media are rapidly advancing, eliminating animal-derived components and boosting reproducibility in cell culture. Qkine launched FRS™ Pioneer, while... -
Japan Leads Global iPSC and Regenerative Medicine: Sumitomo Pharma’s AMCHEPRY Approved as World’s First iPSC-Derived Therapy for Parkinson’s Disease
PlacidWay Japan Overview Japan has achieved a global first with Sumitomo Pharma's AMCHEPRY, an iPSC-derived dopaminergic neural progenitor cell suspension, receiving conditional, time-limited approval for Parkinson's disease on March 6, ... -
Real-Time Bioreactor Monitoring Advances with Raman Spectroscopy, Enhancing Cell Culture Precision and Efficiency
Spectroscopy Online USA Overview Process Raman Spectroscopy, utilizing fiber-optic probes, enables real-time, in-line chemical monitoring in bioreactors, tracking reaction conversion and cell-culture metabolite concentrations without sam... -
FDA Finalizes Flexible CMC Framework, Ending ‘Rule of Three’ for Cell and Gene Therapy Approvals
BioProcess International USA Overview The FDA has issued a finalized "Level 2" guidance document for Chemistry, Manufacturing, and Controls (CMC) flexibilities in cellular and gene therapy (CGT) products, effectively concluding the "Rule... -
Liv Hospital Advances iPSC Reprogramming, Sets Sights on Scalable Production for Regenerative Medicine
Liv Hospital Turkey Overview Liv Hospital's latest research details critical optimizations in induced pluripotent stem cell (iPSC) reprogramming, emphasizing advanced gene delivery systems and optimal vector selection for efficient and s... -
Bioreactor-Based Transient Transfection with HEK 293-F Cells Unlocks Large-Scale HPV VLP Production
MDPI Switzerland Overview A recent study demonstrates a significant advance in biopharmaceutical manufacturing, achieving highly efficient, large-scale production of HPV16 L1/L2 chimeric virus-like particles (VLPs). By leveraging transie... -
Biopharma’s Evolving Blueprint: AGC Biologics Expands Global Capacity, Enzene Drives Continuous Manufacturing Adoption
Pharma Manufacturing USA Overview This news digest highlights several pivotal developments in the biopharmaceutical manufacturing sector, showcasing an industry-wide acceleration towards enhanced capacity and technological innovation. Ke... -
Biomanufacturing Reorients: Geopolitical Forces Drive Sourcing to Qualified, Regional Capacity, with Cellares Pioneering IDMO Smart Factories
Pharma's Almanac USA Overview Geopolitical forces are profoundly reshaping biomanufacturing procurement, driving a surge in demand for 'qualified capacity' – providers with specialized expertise and robust regulatory compliance. This shi... -
Cracking the Cost Code: Cellares’ Automated Platform Targets 75% Reduction in CAR-T Manufacturing, Pinpointing Viral Vectors as Key Driver
IntuitionLabs USA Overview A new analysis highlights viral vectors as the primary cost driver in CAR-T cell therapy manufacturing, prompting an urgent need for more efficient production. While existing closed-system platforms offer incre... -
Cell Therapy Consumables Market Set for $7.53 Billion Surge by 2032, Fueled by Automation and Closed Systems
Credence Research India Overview A new report from Credence Research projects the global cell therapy consumables market will reach $7.53 billion by 2032. This significant growth is primarily driven by the expanding adoption of advanced ...
